BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11864926)

  • 21. Sevoflurane inhibits guanosine 5'-[gamma-thio]triphosphate-stimulated, Rho/Rho-kinase-mediated contraction of isolated rat aortic smooth muscle.
    Yu J; Ogawa K; Tokinaga Y; Hatano Y
    Anesthesiology; 2003 Sep; 99(3):646-51. PubMed ID: 12960549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.
    Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM
    J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism.
    Yoshida M; Sawada T; Ishii H; Gerszten RE; Rosenzweig A; Gimbrone MA; Yasukochi Y; Numano F
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1165-71. PubMed ID: 11451746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
    Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
    Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of nuclear factor-kB activation through RhoA/Rho-kinase pathway in LPS-induced IL-8 production in human cervical stromal cells.
    Shimizu S; Tahara M; Ogata S; Hashimoto K; Morishige K; Tasaka K; Murata Y
    Mol Hum Reprod; 2007 Mar; 13(3):181-7. PubMed ID: 17227815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways.
    Eto M; Kozai T; Cosentino F; Joch H; Lüscher TF
    Circulation; 2002 Apr; 105(15):1756-9. PubMed ID: 11956113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
    Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
    Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A role for the Rho-p160 Rho coiled-coil kinase axis in the chemokine stromal cell-derived factor-1alpha-induced lymphocyte actomyosin and microtubular organization and chemotaxis.
    Vicente-Manzanares M; Cabrero JR; Rey M; Pérez-Martínez M; Ursa A; Itoh K; Sánchez-Madrid F
    J Immunol; 2002 Jan; 168(1):400-10. PubMed ID: 11751986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase.
    Sauzeau V; Le Mellionnec E; Bertoglio J; Scalbert E; Pacaud P; Loirand G
    Circ Res; 2001 Jun; 88(11):1102-4. PubMed ID: 11397774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases.
    van Nieuw Amerongen GP; van Delft S; Vermeer MA; Collard JG; van Hinsbergh VW
    Circ Res; 2000 Aug; 87(4):335-40. PubMed ID: 10948069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-cadherin juxtamembrane domain modulates voltage-gated Ca2+ current via RhoA GTPase and Rho-associated kinase.
    Piccoli G; Rutishauser U; Brusés JL
    J Neurosci; 2004 Dec; 24(48):10918-23. PubMed ID: 15574742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
    Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
    Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular regulation of basal tone in internal anal sphincter smooth muscle by RhoA/ROCK.
    Patel CA; Rattan S
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1747-56. PubMed ID: 17379756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small guanosine triphospatase RhoA and Rho-associated kinase as regulators of trophoblast migration.
    Shiokawa S; Iwashita M; Akimoto Y; Nagamatsu S; Sakai K; Hanashi H; Kabir-Salmani M; Nakamura Y; Uehata M; Yoshimura Y
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5808-16. PubMed ID: 12466390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
    Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
    Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models.
    Vincent L; Soria C; Mirshahi F; Opolon P; Mishal Z; Vannier JP; Soria J; Hong L
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):623-9. PubMed ID: 11950701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
    Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells.
    Kamiyama M; Utsunomiya K; Taniguchi K; Yokota T; Kurata H; Tajima N; Kondo K
    J Atheroscler Thromb; 2003; 10(2):117-23. PubMed ID: 12740486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.